Understanding Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis, affecting millions of people worldwide. It occurs when the protective cartilage that cushions the ends of bones gradually wears down over time, leading to pain, stiffness, and reduced mobility.
Unlike rheumatoid arthritis, osteoarthritis is primarily a degenerative condition driven by mechanical wear, aging, and metabolic factors. The joints most commonly affected include the knees, hips, hands, and spine. As cartilage deteriorates, bones may rub against each other, causing inflammation, bone spurs, and progressive loss of function.
Traditional treatments focus on symptom management through pain medications, corticosteroid injections, and eventually joint replacement surgery. Regenerative medicine offers a different approach: addressing the underlying tissue damage by promoting the body's natural repair mechanisms.
Common Symptoms
- Joint pain that worsens with activity
- Morning stiffness lasting less than 30 minutes
- Reduced range of motion
- Swelling and tenderness around the joint
- A grating or crackling sensation during movement
- Bone spurs or joint deformity in advanced stages
How MSC Therapy May Help
Mesenchymal stem cells (MSCs) offer a regenerative approach to osteoarthritis by addressing the root cause of the condition: cartilage degradation and chronic inflammation. When introduced to damaged joints, MSCs may help stimulate the body's natural repair processes.
MSCs release anti-inflammatory molecules called cytokines, which may help reduce the chronic inflammation that accelerates cartilage breakdown. They also secrete growth factors that support the production of new cartilage cells (chondrocytes) and promote the synthesis of collagen and proteoglycans, the essential building blocks of healthy cartilage.
Research suggests that MSCs derived from Wharton's Jelly are particularly effective due to their youthful potency and strong immunomodulatory properties. Unlike bone marrow-derived cells, they carry minimal risk of immune rejection and maintain robust regenerative capacity.
Our Treatment Approach
Comprehensive Assessment
Thorough evaluation including imaging studies and joint function tests to determine the extent of cartilage damage and create a personalized treatment plan.
IV MSC Infusion
Systemic intravenous infusion of Wharton's Jelly MSCs to reduce whole-body inflammation and support the immune environment for healing.
Ultrasound-Guided Joint Injection
Precision delivery of MSCs directly into the affected joint under ultrasound guidance, ensuring accurate placement for optimal cartilage regeneration.
Complementary Therapies
Supporting treatments including exosome co-therapy, physiotherapy guidance, and nutritional optimization to enhance and sustain regenerative outcomes.